WEC
CBST

Winslow Evans & Crocker’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Winslow Evans & Crocker’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-144
Closed -$9.49K – 1441
2014
Q3 		$9.49K Buy
+144
New +$9.46K ﹤0.01% 905
2014
Q1 		– Sell
-3,200
Closed -$220K – 1470
2013
Q4 		$220K Buy
+3,200
New +$207K 0.08% 271

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Winslow Evans & Crocker's CBST Position: Q4 2014 in Review

Winslow Evans & Crocker sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 144 shares — an estimated $9.49K sold.

Winslow Evans & Crocker first reported a position in CBST in Q4 2013 and held it in 2 quarters. The position peaked at $220K in Q4 2013. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Winslow Evans & Crocker reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Winslow Evans & Crocker sold 144 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $9.49K.
  • Winslow Evans & Crocker first reported a position in CUBIST PHARMACEUTICALS INC in Q4 2013 and held it in 2 quarters.
  • Winslow Evans & Crocker's CUBIST PHARMACEUTICALS INC position peaked at $220K in Q4 2013.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Winslow Evans & Crocker's 13F filing for Q4 2014, filed 22 Jan 2015.